NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines
The paper discusses the position of beta-blockers, nebivolol in particular, in the Reappraisal 2009 of ESH/ESC Guidelines on arterial hypertension (AH) management. Nebivolol is not only highly selective towards beta-1 angiotensin II receptors, but also metabolically neutral, and therefore, could be...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2150 |